2021) maps the input of scRNA-seq and surface protein expression into a shared low-dimensional space with principal component analysis (PCA ... However, tuning the hyperparameters of DCCA, especially ...
ResMed Inc . (NYSE:RMD) reported its financial results for the second quarter of fiscal year 2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.43, surpassing the forecasted ...